Genmab — April 2020
-
Og vi kommer til at runde 20 mio arbejdsløse i US. Det kan umuligt end andet få et spillover effekt ind i 2021 med lavere samlet forbrug og dermed lavere vækst (men set i forhold til i år bliver det naturligvis en flot vækst)
-
Samle op 10% længere nede? Med de fremtidsudsigter du åbenbart frygter, eller måske håber på. Altså lige en god aftale for Genmab, den stiger, du sælger på toppen, og køber igen på bunden. Held og lykke med dine spådomme.Det er det jeg kalder spekulation, og det er helt ok for mig, men det er mange år siden jeg droppede det.
-
God morgen.
-
Remdesivir må nu bruges i Tyskland til meget syge covid-19 patienter https://www.sueddeutsche.de/gesundheit/coronavirus-covid-19-forschung-newsblog-1.4788734
-
Vi hører nok snart nyt fra Gilead's egne 2 store fase 3 studier, som har PCD i maj. https://clinicaltrials.gov/ct2/show/NCT04292899?term=NCT04292899&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/NCT04292730?term=NCT04292730&draw=2&rank=1https://clinicaltrials.gov/ct2/show/NCT04292730?term=NCT04292730&draw=2&rank=1
-
2 tilsvarende kinesiske studier har PCD i denne måned.https://clinicaltrials.gov/ct2/show/NCT04252664?term=NCT04252664&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/NCT04257656?term=NCT04257656&draw=2&rank=1
-
anybody got the current UBS target price? yesterday:
UBS Reiterates Neutral Rating on Genmab A/S https://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Neutral+Rating+on+Genmab+AS+(GEN%3ADC)+(GMAB)/16717644.html -
I think it is 1460 or 1480.
-
Very recently
-
But Genmab also figure on the UBS Most Preffered List for European Pharma and Biotech Stocks.
-
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) https://www.globenewswire.com/news-release/2020/04/08/2013405/0/en/Regeneron-and-Zai-Lab-Announce-Regional-Strategic-Collaboration-for-REGN1979-CD20xCD3-Bispecific-Antibody.html
-
shame we don't have one of these: Karyopharm Launches Multiple Myeloma Drug Selinexor in COVID-19 Clinical Trial https://www.myelomacrowd.org/karyopharm-launches-multiple-myeloma-drug-selinexor-in-covid-19-clinical-trial/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind